Success Metrics

Clinical Success Rate
86.8%

Based on 66 completed trials

Completion Rate
87%(66/76)
Active Trials
10(9%)
Results Posted
59%(39 trials)
Terminated
10(9%)

Phase Distribution

Ph phase_4
36
33%
Ph not_applicable
38
35%
Ph phase_3
11
10%
Ph early_phase_1
2
2%
Ph phase_1
9
8%
Ph phase_2
12
11%

Phase Distribution

11

Early Stage

12

Mid Stage

47

Late Stage

Phase Distribution108 total trials
Early Phase 1First-in-human
2(1.9%)
Phase 1Safety & dosage
9(8.3%)
Phase 2Efficacy & side effects
12(11.1%)
Phase 3Large-scale testing
11(10.2%)
Phase 4Post-market surveillance
36(33.3%)
N/ANon-phased studies
38(35.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.5%

66 of 81 finished

Non-Completion Rate

18.5%

15 ended early

Currently Active

10

trials recruiting

Total Trials

110

all time

Status Distribution
Active(13)
Completed(66)
Terminated(15)
Other(16)

Detailed Status

Completed66
unknown15
Terminated10
Recruiting6
Withdrawn5
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
110
Active
10
Success Rate
86.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.9%)
Phase 19 (8.3%)
Phase 212 (11.1%)
Phase 311 (10.2%)
Phase 436 (33.3%)
N/A38 (35.2%)

Trials by Status

suspended11%
terminated109%
active_not_recruiting44%
recruiting65%
withdrawn55%
completed6660%
not_yet_recruiting33%
unknown1514%

Recent Activity

10 active trials
Showing 5 of 110
recruitingphase_3

Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes

NCT07733167
active_not_recruitingphase_2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

NCT01059786
recruitingphase_3

R.E.C.K vs Exparel in Robotic Nephrectomy

NCT07092566
not_yet_recruitingnot_applicable

Vasopressor Agents in Pulmonary Hypertension Crisis

NCT07667829
completednot_applicable

The EPIVER Randomized Controlled Trial

NCT04573751
View all 110 trials

Clinical Trials (110)

Showing 20 of 110 trialsScroll for more
NCT07733167Phase 3

Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes

Recruiting
NCT01059786Phase 2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Active Not Recruiting
NCT07092566Phase 3

R.E.C.K vs Exparel in Robotic Nephrectomy

Recruiting
NCT07667829Not Applicable

Vasopressor Agents in Pulmonary Hypertension Crisis

Not Yet Recruiting
NCT04573751Not Applicable

The EPIVER Randomized Controlled Trial

Completed
NCT06418308Phase 4

Intrathecal Dexmedetomidine vs Epinephrine

Completed
NCT05972681Phase 4

The PAIN (Pelvic Area Injection for Numbness) Study

Terminated
NCT06416969Early Phase 1

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Recruiting
NCT00678145Phase 2

Mechanisms of Hypoglycemia Associated Autonomic Failure

Terminated
NCT04432597Phase 1

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Active Not Recruiting
NCT05738148Phase 1

Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation

Active Not Recruiting
NCT06112548Not Applicable

The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

Completed
NCT07144267Not Applicable

Comparison of Milrinone and Epinephrine on TAPSE

Not Yet Recruiting
NCT05488847Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Active Not Recruiting
NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting
NCT03826524Phase 4

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Recruiting
NCT02692313Early Phase 1

Dose Response of Epinephrine

Completed
NCT02356159Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Completed
NCT02722746Phase 1

The Prevention of Hypotension After Epidural Analgesia After Major Surgery

Completed
NCT03554473Phase 1

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Completed

Drug Details

Intervention Type
DRUG
Total Trials
110